Delos Capital

Funding rounds backed by Delos Capital.

Export CSV
Funding disclosed in full
$83M
Median round
$25M
Rounds in calculation
3
3 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Rejoni

Develops a hydrogel system to treat uterine health conditions and prevent scarring

$25MSeries AHealthtechUnited States
8 participantsAmed VenturesAscension VenturesCatalyst Health VenturesClavystBioDelos CapitalFemHealth VenturesIyengar CapitalSparta Group
TRex Bio

Develops precision immunoregulatory medicines based on tissue Treg biology

$50MUndisclosedBiotechUnited States
11 participantsAffinity Asset AdvisorsAlexandria Venture InvestmentsAvego BioScience CapitalBalyasny Asset ManagementDelos CapitalEli Lilly and CompanyJanus Henderson InvestorsJohnson & Johnson Innovation – JJDCPfizer VenturesPolaris PartnersSV Health Investors
STRM.BIO

Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy

$8MSeed2BiotechUnited States
4 participantsBlue Bay Capital FundBoehringer Ingelheim VenturesDelos CapitalRecordati